Renewal Partners Portfolio Performance
Strong Financial Return:
- 15 year track record to valuation date*
- 12.2% IRR**
Lower Risk Profile:
- 40 portfolio companies: 8 exits, 24 active and 8 write-offs***
- 80% of portfolio either exited or still active - a very high ratio in the venture community
Strong Multiples on Sales and Exits:
- 25% of Exits >15X
- 75% of Exits > 3X
* Valuation by Evans & Evans completed July 2008
** Not including dividends, interest earned or associated costs
*** Represent all equity and convertible debt investments of at least C$50,000 by Renewal Partners in Renewal2 sectors
Renewal2 Investment Fund is a Limited Partnership Fund and all investors must qualify as accredited investors.
This document is not intended to be an offer for the sale or purchase or solicitation of securities in Renewal2 or otherwise. Such an offer may only be made in compliance with disclosure and delivery requirements under applicable securities laws and will be limited to prescribed categories of investors. Any statement in any future subscription documentation shall be deemed to modify or supersede any statement in this document. Renewal Partners’ past performance is not a guarantee of the future performance of Renewal Partners or Renewal2. Statutory rights to cancel investment obligations made in the future may arise in specified circumstances. Investors should consult their own legal, tax and financial advisors before considering an investment in this fund. Material prepared by Evans & Evans an independent valuation firm headquartered in Vancouver, B.C. Evans & Evans did rely only on the information, materials and representations provided to it by Renewal Partners. Evans & Evans did assume that the information provided was accurate, correct and complete, and that there are no material omissions of information that would affect the conclusions contained in the summary. Evans & Evans did attempt to verify the accuracy or completeness of the data and information available. Should the assumptions used in the summary be found to be incorrect, then the valuation conclusion may be rendered invalid and would likely have to be reviewed in light of correct and/or additional information. Evans & Evans denies any responsibility, financial or legal or other, for any use and/or improper use of the Summary however occasioned. Evans & Evans reserves the right to review all information and calculations included or referred to in the Summary. Evans & Evans is not an investment advisory service and makes no recommendations, either expressed or implied, as to the suitability of any of the funds or companies described herein or any of their respective securities, as investments.
